Evidence map›Paper›PMID 34349111›Full record

ArticleNature communications2021

GIANA allows computationally-efficient TCR clustering and multi-disease repertoire classification by isometric transformation.

Hongyi Zhang, Xiaowei Zhan, Bo Li

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 88 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 1 synthesis or guideline pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hongyi ZhangLyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA.
Xiaowei ZhanDepartment of Population and Data Science, UT Southwestern Medical Center, Dallas, TX, USA.
Bo LiLyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA. bo.li@utsouthwestern.edu.ORCID http://orcid.org/0000-0002-8617-900X
Southwestern Medical Center · USSouthwestern Medical Center

Funding

Antigen-independent prediction and biomarker identification of cancer-specific T cellsR01CA245318 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI LI, BO · 2020 to 2024
$1.9M
Tools for integrative genomics and disease association study for the X chromosomeR01GM126479 · NIGMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LIU, DAJIANG · 2018 to 2021
$1.2M
NCI NIH HHS R01 CA245318NIGMS NIH HHS R01 GM126479
6 · The paper itself

Abstract

Similarity in T-cell receptor (TCR) sequences implies shared antigen specificity between receptors, and could be used to discover novel therapeutic targets. However, existing methods that cluster T-cell receptor sequences by similarity are computationally inefficient, making them impractical to use on the ever-expanding datasets of the immune repertoire. Here, we developed GIANA (Geometric Isometry-based TCR AligNment Algorithm) a computationally efficient tool for this task that provides the same level of clustering specificity as TCRdist at 600 times its speed, and without sacrificing accuracy. GIANA also allows the rapid query of large reference cohorts within minutes. Using GIANA to cluster large-scale TCR datasets provides candidate disease-specific receptors, and provides a new solution to repertoire classification. Querying unseen TCR-seq samples against an existing reference differentiates samples from patients across various cohorts associated with cancer, infectious and autoimmune disease. Our results demonstrate how GIANA could be used as the basis for a TCR-based non-invasive multi-disease diagnostic platform.

Indexed as

AlgorithmsCluster AnalysisComplementarity Determining RegionsCOVID-19Diagnosis, DifferentialEpitopes, T-LymphocyteHumansMultiple SclerosisNeoplasmsReceptors, Antigen, T-CellSARS-CoV-2Sequence AlignmentComplementarity Determining RegionsEpitopes, T-LymphocyteReceptors, Antigen, T-Cell

Identifiers

PMID34349111
PMCPMC8339063
OpenAlexW3187834303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.